Third, combination of BRRF1 and LMP1 transduction could be attempted in various cancers to determine if they will achieve high expression of BTN2A1/BTN3A1 proteins, especially among those NPC cell lines unresponsive to BRRF1 alone. This evidence concerns the gene BTN3A1 and nasopharyngeal carcinoma.